Previous 10 | Next 10 |
Gainers: Inotiv ( NOTV ) +18% . IO Biotech ( IOBT ) +16% . SOPHiA GENETICS ( SOPH ) +10% . Apyx Medical ( APYX ) +9% . Rhythm Pharmaceuticals ( RYTM ) +9% . Losers: Regulus Therapeutics ( RGLS ) -14% . Aerovate...
Unitedv Maritime ( USEA ) -34% . Regulus Therapeutics ( RGLS ) -22% . Mawson Infrastructure Group ( MIGI ) -10% to raise $6.4M in stock and warrants offering. Qurate Retail ( QRTEB ) -6% . NexImmune ( NEXI ) -8% . Akanda ...
Regulus Therapeutics Announces Receipt of FDA Orphan Drug Designation for RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) PR Newswire SAN DIEGO , June 21, 2022 /PRNewswire/ -- Regulus Therapeutics Inc . (Nasdaq: ...
Regulus Therapeutics Announces First Subject Dosed in Phase 1 Single-Ascending Dose (SAD) Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) PR Newswire SAN DIEGO , June 13, 2022 /PRNewswire/ -- Regulu...
Regulus Appoints Amin Kamel, Ph.D., as Vice President, DMPK PR Newswire SAN DIEGO , June 2, 2022 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines tar...
3 Penny Stocks to Watch in June 2022 With the stock market up today, those investing in penny stocks are excited for what the future may bring. Now, with penny stocks, it is crucial to remember that risk will always be inherently high. This is due to the fact that penny stocks are u...
3 Penny Stocks to Add to Your Watchlist Right Now If you’re looking for the best penny stocks to buy, there are hundreds of options to choose from. And with a rather positive day of trading for penny stocks and blue chips , the market is ripe with opportunity. But, trading pe...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Penny stocks can multiply in value quickly, these picks have 10x potential this year. Regulus Therapeutics ( RGLS ): Represents traditional pharma potential and proven returns for traders. Imperial Pet...
Regulus Therapeutics, Inc. (RGLS) Q1 2022 Earnings Conference Call May 12, 2022, 17:00 ET Company Participants Crispina Calsada - CFO Joseph Hagan - President, CEO & Director Conference Call Participants Yi Chen - H.C. Wainwright & Co. Presentation Operator Good day, and welcome to th...
Regulus Therapeutics press release (NASDAQ:RGLS): Q1 GAAP EPS of -$0.05. Research and development expenses were $3.7M. For further details see: Regulus Therapeutics GAAP EPS of -$0.05
News, Short Squeeze, Breakout and More Instantly...
Regulus Therapeutics Inc. Company Name:
RGLS Stock Symbol:
NASDAQ Market:
Regulus Therapeutics Inc. Website:
Regulus Therapeutics Announces Positive Topline Data from the Third Cohort of Patients in its Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) PR Newswire Continued mechanistic dose resp...
Regulus Therapeutics Announces Expected Addition to the Russell 3000® and Russell 2000® Indexes PR Newswire SAN DIEGO , June 4, 2024 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and devel...
Regulus Therapeutics Announces Promotion of Rekha Garg, M.D., M.S., to Chief Medical Officer PR Newswire SAN DIEGO , May 16, 2024 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of inn...